• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Infectious diseases

    Infectious diseases

    JournalISSN 2374-4235eISSN 2374-4243中科院 医学 4区

    年发文量

    研究主题

    论文(2719)

    排序
    1Blood-borne, Yet Slow: What Delays CNS Disease in Acanthamoeba and Balamuthia ?
    Ruqaiyyah Siddiqui,Naveed Ahmed Khan
    2026
    引用
    AI阅读
    加入学术空间
    2Protecting Informed Choice in Ebola Vaccination for Healthcare Workers.
    Christophe Malomalo Limanga

    Protecting healthcare workers during Ebola outbreaks is an urgent public health responsibility. Vaccination can contribute to that protection, but an institutional recommendation can become difficu...

    2026
    引用
    AI阅读
    加入学术空间
    3High Proportion of Pregnant Women and Migrants among Adults Hospitalised with Varicella in Belgium 2012-2022: a Case Series Study
    Emma Buttice,Sara Cherkaoui,Philippe Clevenbergh, Kaoutar Abdellaoui, Quentin Lamelyn, Sandrine Roisin,Sigi Van den Wijngaert, Anne Tilmanne,Charlotte Martin,Nicolas Dauby

    Objectives To describe the characteristics and outcomes of adults hospitalised with varicella in Belgium, where universal varicella vaccination is not offered in children and to identify implications for targeted vaccination strategies. Methods A retrospective study was conducted in three Belgian hospitals during a 10-year period (2012-2022), including adults hospitalised >24 h with varicella or varicella pneumonia, identified through microbiological results and minimal clinical datasets. Demographic, clinical, and outcome data were analysed. Results Among 74 hospitalised adults, 13 (17.6%) had varicella pneumonia. Most patients were male migrants living in precarious conditions, and a substantial proportion were undocumented. Pregnant women accounted for a quarter of admissions, and many reported recent contacts with a child with varicella. Most patients received antiviral therapy and had favourable outcomes; one death occurred in an immunocompromised patient. A notable fraction of cases would have been missed by routine surveillance relying on minimal clinical data alone. Conclusions In the three studied hospitals, adult hospitalisations caused by varicella cluster in socially vulnerable groups and pregnant women. Varicella vaccination for newly arrived refugees and systematic identification and vaccination of seronegative women of childbearing age could reduce the burden of varicella hospitalisations.

    2026
    引用
    AI阅读
    加入学术空间
    4Toxicity and Effectiveness of Low-Dose and Conventional-Dose Co-Trimoxazole for Treatment of Pneumocystis Jirovecii Pneumonia in Christchurch, New Zealand: a Retrospective Cohort Study
    Aileen Harwood,Maya Wernick, Nicholas M. Douglas

    Background Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection which primarily affects immunocompromised individuals. The recommended dose of co-trimoxazole for treatment of PJP is 15–20 mg/kg/day of the trimethoprim component based on an underpowered 1975 study in 20 children with cancer. While this dose is effective, a lower dose may be sufficient and cause less toxicity.Method We conducted a retrospective cohort study of patients treated for ‘proven’ or ‘probable’ PJP at Christchurch Public Hospital, New Zealand between January 2018 and November 2023. We compared treatment limiting adverse drug reactions (ADR) and 30-day all-cause mortality in patients initiated on a conventional dose of co-trimoxazole (≥12.5 mg/kg/day) versus those initiated on a low dose of co-trimoxazole (<12.5 mg/kg/day).Results A total of 148 patients with a positive Pneumocystis jirovecii PCR or immunofluorescence result were treated with co-trimoxazole of whom 139 were categorised as having ‘proven’ or ‘probable’ PJP (36 low-dose (25.9%), 103 conventional-dose (74.1%)). A higher proportion of patients receiving conventional-dose co-trimoxazole required a treatment alteration due to an ADR (43.7%, 45/103) than patients receiving low-dose co-trimoxazole (16.7%, 6/36). There was no statistically significant difference in 30-day all-cause mortality between the low- and conventional-dose groups (adjusted hazard ratio for low- versus conventional-dose = 0.76, 95% confidence interval 0.29–1.98, p = 0.57).Conclusions In this comparatively large retrospective cohort, low-dose co-trimoxazole was associated with fewer treatment-limiting ADRs without an observed increase in mortality. These findings add to the growing body of observational evidence supporting the use of lower co-trimoxazole doses for the treatment of PJP.

    2026
    引用
    AI阅读
    加入学术空间
    5Two Vaccination Streams, One Evidence Gap: Generating Evidence for Ervebo Against Bundibugyo Virus
    Christophe Malomalo Limanga,Salomon Batina-Agasa,Mbo Mukonkole Jean-Paulin, Camile-Remy Atoba Bokele,Paul Kambale-Kombi, Willy Tshitenge Babanya Kabudi, Jacques Ossinga Bassandja, Lucien Bolukaoko Bome,Jean Paul Bambale Limengo,Dieu Merci Mbumba Lupaka, Eric Jakwong’a Moro, Victoire Nguru,
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2719 篇论文

    高被引作者

    作者引用发文
    Shin Jie Yong25882
    Reto Brun12601
    Ola Weiland40610
    Jaana Vuopio3396
    Jarmo Oksi2534
    Johanna Vilhonen2412
    Niina Susanna Koivuviita2311
    Beatriz Ibarra-Molero2301
    George Makhatadze2301
    José Manuel Sánchez Ruiz (Jose M. Sanchez Ruiz)2301

    高产作者

    作者引用发文
    A. MELVIN RAMSAY2327
    RONALD T.D. EMOND2326
    Scarpa Fabio4821
    Massimo Ciccozzi4821
    Magnus Rasmussen17916
    Erin M Dunbar014
    Magnus Gisslén15314
    Pd Welsby014
    Francesco Branda5112
    Giancarlo Ceccarelli3112

    相关期刊

    Diagnostic Microbiology and Infectious Disease
    European Journal of Clinical Microbiology & Infectious Diseases
    Journal of Infection and Chemotherapy
    Journal of infection in developing countries
    Infection & chemotherapy
    Infectious diseases and therapy
    Open Forum Infectious Diseases
    Infection
    Infectious Disease Reports
    Brazilian Journal of Infectious Diseases